NDC Code(s) : 24987-200-10, 24987-200-20
Packager : Covis Pharmaceuticals Inc.
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
Uroxatralalfuzosin HCl TABLET, EXTENDED RELEASE | ||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
PRINCIPAL DISPLAY PANEL
PRINCIPAL DISPLAY PANEL - 10 mg Tablet Label
NDC 24987-200-10 X-010
Uroxatral
®
alfuzosin HCl 10 mg
Extended-Release Tablets
1 Bottle Rx only
100 Tablets
Keep out of reach of children
Covis
Mfd. for:
Covis Pharmaceuticals, Inc.
Cary, NC 27511 ©2013
Origin France
100113 Rev. 4/13 50106150
See package insert for dosage information.
Protect from light and moisture.
Dispense in a tight, light-resistant
container as described in the USP.
Store at 25°C (77°F); excursions permitted
to 15-30°C (59-86°F) [see USP Controlled
Room Temperature].